Regulation of blood as a starting material for ATMP manufacture

The HTA and MHRA have agreed to extend their existing policy relating to dendritic cells to allow collection of blood as a starting material for an ATMP to be performed under either a Tissues and Cells or Blood Establishment Licence.

This will make it more straightforward to procure blood and increase the number of sites in the UK where this activity can occur without increasing the number of licences required.